パーキンソン病の人はどんな薬を欲しがるのでしょうか

Kevin McFarthing¹, Tiago Fleming Outeiro^2,3, Maria Carmo Bastos⁴

¹Parkinson's Research Advocate, Oxford, UK.

Journal of Parkinson's disease

|August 26, 2025

まとめ

パーキンソン病 (PD) の患者は症状をコントロールし進行を遅らせるパーソナライズされた薬を望んでいます生活の質と快適さに焦点を当てた患者のニーズが新しいパーキンソン病の治療法の開発を導くべきです

科学分野:

神経科学
薬理学について
患者中心の研究

背景:

パーキンソン病 (PD) は,臨床的表象,病理,および進行において有意な異質性を持つ複雑な神経疾患である.
患者のニーズを理解することはパーキンソン病の効果的な治療法の開発に不可欠です

研究の目的:

パーキンソン病 (PwP) の患者に対する薬の望ましい特性を探求する.
パーキンソン病の薬の開発における患者中心のアプローチの重要性を強調する.

主な方法:

望ましい薬の属性に関する患者の視点の定性分析
パーキンソン病の現在のおよび潜在的な治療戦略のレビュー,症状 (ST) と疾患修正 (DMT) 治療を含む.

主要な成果:

PwPは,最適の有効性,便利性,そして手頃な価格を提供する医薬品を優先します.
患者から報告された不快な症状は,治療介入の重要なターゲットです.
早期診断と症状前治療は PDの進行を抑えるのに有望です

結論:

パーキンソン病の薬局図はパーソナライズされた治療カクテルに焦点を当てるべきです
研究者とPwPの協力は薬の開発を患者のニーズに合わせて生活の質を改善するために不可欠です
パーキンソン病の治療の可能性を伝えることはパーキンソン病のコミュニティーに希望を持てるために不可欠です

キーワード:

臨床試験病気の変化薬物開発非運動症状患者によって報告されたアウトカム治療薬

さらに関連する動画

16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.5K

06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.9K

関連する概念動画

01:24

Parkinson's Disease: Treatment

377

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

377

01:15

Parkinson's Disease: Overview

703

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

703

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:22

Alzheimer's Disease: Treatment

260

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

260

01:26

Cholinergic Antagonists: Therapeutic Uses

871

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

871

01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

380

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

380

関連する実験動画